Get started
IRadimed Corp.IRadimed Corp.IRadimed Corp.

IRadimed Corp.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs
Full chart
Full chart

Compare with IRadimed Corp.



Key stats


Market capitalization
‪1.01 B‬ EUR
Dividend yield (indicated)
0.84%
Price to earnings Ratio (TTM)
50.0
Basic EPS (TTM)
1.5 EUR
Net income (FY)
‪19.14 M‬ EUR
Revenue (FY)
‪71.36 M‬ EUR
Shares float
‪8.33 M‬
Beta (1Y)
0.34

Latest earnings


Last report date
Jul 31, 2026
Report period
Q2 2026
EPS
0.40 EUR
Revenue
‪17.92 M‬ EUR
Earnings call summary

Q2 revenue reached $20.5M with strong demand for the new 3870 MRI IV pump, especially quad systems, driving bookings to more than double shipments. Gross margin dipped to 74% due to ramp-up costs but is expected to recover as efficiencies improve. Full-year guidance is reaffirmed.

Employees


Employees (FY)
166
Change (1Y)
+6+3.75%
Revenue / Employee (1Y)
‪429.88 K‬ EUR
Net income / Employee (1Y)
‪115.30 K‬ EUR

Details


Sector
Health Technology
Industry
Medical Specialties
CEO
Roger Susi
Website
iradimed.com
Headquarters
Orlando
Founded
1992
IPO date
Jul 16, 2014
ISIN
US46266A1097
CUSIP
46266A109
FIGI
BBG00NRB6J61
Identifiers
ISIN US46266A1097
CFI code
ESVUFR
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Orlando, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IWO
iShares Russell 2000 Growth Fund
Weight0.05%
Market value‪7.20 M‬
DFMC
U.S. Micro Cap Portfolio: ETF Class Shares
Weight0.05%
Market value‪4.02 M‬
FYC
First Trust Small Cap Growth AlphaDEX Fund
Weight0.25%
Market value‪3.55 M‬
IHI
iShares U.S. Medical Devices ETF
Weight0.10%
Market value‪3.53 M‬
IWC
iShares Microcap ETF
Weight0.18%
Market value‪2.67 M‬
DES
WisdomTree U.S. SmallCap Dividend Fund
Weight0.12%
Market value‪2.58 M‬
VHT
Vanguard Health Care ETF
Weight0.01%
Market value‪2.38 M‬
FSMD
Fidelity Small-Mid Multifactor ETF
Weight0.08%
Market value‪2.08 M‬
AVSC
Avantis U.S Small Cap Equity ETF
Weight0.06%
Market value‪1.77 M‬
XHE
State Street SPDR S&P Health Care Equipment ETF
Weight1.08%
Market value‪1.75 M‬
PSC
Principal U.S. Small-Cap ETF
Weight0.07%
Market value‪1.61 M‬

Explore more ETFs 

Frequently asked questions


The current price of 46K is 78.5 EUR — it has decreased by −0.63% in the past 24 hours. Watch IRadimed Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IRadimed Corp. stocks are traded under the ticker 46K.
46K stock has fallen by −4.27% compared to the previous week, the month change is a −9.25% fall, over the last year IRadimed Corp. has showed a 30.83% increase.
We've gathered analysts' opinions on IRadimed Corp. future price: according to them, 46K price has a max estimate of 102.14 EUR and a min estimate of 98.74 EUR. Watch 46K chart and read a more detailed IRadimed Corp. stock forecast: see what analysts think of IRadimed Corp. and suggest that you do with its stocks.
46K reached its all-time high on Mar 5, 2026 with the price of 89.5 EUR, and its all-time low was 14.5 EUR and was reached on Mar 17, 2020. View more price dynamics on 46K chart.
See other stocks reaching their highest and lowest prices.
46K stock is 0.64% volatile and has beta coefficient of 0.34. Track IRadimed Corp. stock price on the chart and check out the list of the most volatile stocks — is IRadimed Corp. there?
Today IRadimed Corp. has the market capitalization of ‪1.03 B‬, it has decreased by −5.71% over the last week.
Yes, you can track IRadimed Corp. financials in yearly and quarterly reports right on TradingView.
IRadimed Corp. is going to release the next earnings report on Oct 29, 2026. Keep track of upcoming events with our Earnings Calendar.
46K earnings for the last quarter are 0.40 EUR per share, whereas the estimation was 0.39 EUR resulting in a 4.55% surprise. The estimated earnings for the next quarter are 0.47 EUR per share. See more details about IRadimed Corp. earnings.
IRadimed Corp. revenue for the last quarter amounts to ‪17.92 M‬ EUR, despite the estimated figure of ‪17.82 M‬ EUR. In the next quarter, revenue is expected to reach ‪20.14 M‬ EUR.
46K net income for the last quarter is ‪4.57 M‬ EUR, while the quarter before that showed ‪5.04 M‬ EUR of net income which accounts for 0.00% change. Track more IRadimed Corp. financial stats to get the full picture.
Yes, 46K dividends are paid quarterly. The last dividend per share was 0.17 EUR. As of today, Dividend Yield (TTM)% is 0.80%. Tracking IRadimed Corp. dividends might help you take more informed decisions.
IRadimed Corp. dividend yield was 0.70% in 2025, and payout ratio reached 38.88%. The year before the numbers were 0.82% and 29.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 8, 2026, the company has 166 employees. See our rating of the largest employees — is IRadimed Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRadimed Corp. EBITDA is ‪25.55 M‬ EUR, and current EBITDA margin is 32.59%. See more stats in IRadimed Corp. financial statements.
Like other stocks, 46K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRadimed Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IRadimed Corp. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IRadimed Corp. stock shows the buy signal. See more of IRadimed Corp. technicals for a more comprehensive analysis.